SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 2nd, 2020 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2020, between Vaxart, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).